These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36736832)

  • 1. Impact of the von Willebrand factor-ADAMTS-13 axis on the risk of future venous thromboembolism.
    Edvardsen MS; Hansen ES; Ueland T; Aukrust P; Brækkan SK; Morelli VM; Hansen JB
    J Thromb Haemost; 2023 May; 21(5):1227-1237. PubMed ID: 36736832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer.
    Pépin M; Kleinjan A; Hajage D; Büller HR; Di Nisio M; Kamphuisen PW; Salomon L; Veyradier A; Stepanian A; Mahé I
    J Thromb Haemost; 2016 Feb; 14(2):306-15. PubMed ID: 26589836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism.
    Edvardsen MS; Hindberg K; Hansen ES; Morelli VM; Ueland T; Aukrust P; Brækkan SK; Evensen LH; Hansen JB
    Blood Adv; 2021 Jan; 5(1):224-232. PubMed ID: 33570640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of vWF, ADAMTS-13 and Thrombospondin-1 in Venous Thromboembolism and Relating Them to the Presence of Factor V Leiden Mutation.
    Al-Awadhi A; Marouf R; Jadaon MM; Al-Awadhy MM
    Clin Appl Thromb Hemost; 2024; 30():10760296231223195. PubMed ID: 38225166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in plasma a disintegrin and metalloprotease with thrombospondin type-1 repeats-13 and von Willebrand factor levels in venous thromboembolic patients.
    Karakaya B; Tombak A; Serin MS; Tiftik N
    Hematology; 2016 Jun; 21(5):295-9. PubMed ID: 26872106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effects of plasma von Willebrand factor and platelet measures on the risk of incident venous thromboembolism.
    Edvardsen MS; Hansen ES; Hindberg K; Morelli VM; Ueland T; Aukrust P; Brækkan SK; Evensen LH; Hansen JB
    Blood; 2021 Dec; 138(22):2269-2277. PubMed ID: 34161566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of von Willebrand factor and ADAMTS-13 antigen and activity levels in sickle cell disease patients in Kuwait.
    Al-Awadhi A; Adekile A; Marouf R
    J Thromb Thrombolysis; 2017 Jan; 43(1):117-123. PubMed ID: 27613177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased von Willebrand factor over decreased ADAMTS-13 activity is associated with poor prognosis in patients with advanced non-small-cell lung cancer.
    Guo R; Yang J; Liu X; Wu J; Chen Y
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28374895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)Thrombosis.
    Favaloro EJ; Henry BM; Lippi G
    Semin Thromb Hemost; 2021 Jun; 47(4):400-418. PubMed ID: 33893632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated plasma levels of plasminogen activator inhibitor-1 are associated with risk of future incident venous thromboembolism.
    Frischmuth T; Hindberg K; Aukrust P; Ueland T; Braekkan SK; Hansen JB; Morelli VM
    J Thromb Haemost; 2022 Jul; 20(7):1618-1626. PubMed ID: 35289062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of ADAMTS-13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis Study.
    Obermeier HL; Riedl J; Ay C; Koder S; Quehenberger P; Bartsch R; Kaider A; Zielinski CC; Pabinger I
    Res Pract Thromb Haemost; 2019 Jul; 3(3):503-514. PubMed ID: 31294335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased ADAMTS13 activity in patients with venous thromboembolism.
    Mazetto BM; Orsi FL; Barnabé A; De Paula EV; Flores-Nascimento MC; Annichino-Bizzacchi JM
    Thromb Res; 2012 Dec; 130(6):889-93. PubMed ID: 23031329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated preoperative von Willebrand factor is associated with perioperative thrombosis in infants and neonates with congenital heart disease.
    Hunt R; Hoffman CM; Emani S; Trenor CC; Emani SM; Faraoni D; Kimchi-Sarfaty C; Ibla JC
    J Thromb Haemost; 2017 Dec; 15(12):2306-2316. PubMed ID: 28981194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of Thrombospondin 1 to von Willebrand Factor and ADAMTS-13 in Sickle Cell Disease Patients of Arab Ethnicity.
    Al-Awadhi A; Adekile A; Marouf R
    Acta Haematol; 2021; 144(2):182-189. PubMed ID: 32987383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Willebrand factor/ADAMTS-13 interactions at birth: implications for thrombosis in the neonatal period.
    Katneni UK; Ibla JC; Hunt R; Schiller T; Kimchi-Sarfaty C
    J Thromb Haemost; 2019 Mar; 17(3):429-440. PubMed ID: 30593735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated plasma D-dimer levels are associated with risk of future incident venous thromboembolism.
    Hansen ES; Rinde FB; Edvardsen MS; Hindberg K; Latysheva N; Aukrust P; Ueland T; Michelsen AE; Hansen JB; Brækkan SK; Morelli VM
    Thromb Res; 2021 Dec; 208():121-126. PubMed ID: 34763296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that high von Willebrand factor and low ADAMTS-13 levels independently increase the risk of a non-fatal heart attack.
    Crawley JT; Lane DA; Woodward M; Rumley A; Lowe GD
    J Thromb Haemost; 2008 Apr; 6(4):583-8. PubMed ID: 18194418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. von Willebrand Factor and Venous Thromboembolism: Pathogenic Link and Therapeutic Implications.
    Calabrò P; Gragnano F; Golia E; Grove EL
    Semin Thromb Hemost; 2018 Apr; 44(3):249-260. PubMed ID: 28898897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High factor VIII, von Willebrand factor, and fibrinogen levels and risk of venous thromboembolism in blacks and whites.
    Payne AB; Miller CH; Hooper WC; Lally C; Austin HD
    Ethn Dis; 2014; 24(2):169-74. PubMed ID: 24804362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. von Willebrand factor propeptide-to-antigen ratio in HIV-infected pregnancy: Evidence of endothelial activation.
    Schapkaitz E; Libhaber E; Jacobson BF; Meiring M; Büller HR
    J Thromb Haemost; 2021 Dec; 19(12):3168-3176. PubMed ID: 34409729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.